Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1058 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-02-19 (stocktitan.net)
Charles River Labs Posts Q4 Loss on $215M Impairment, Forecasts 2025 Revenue Decline | CRL Stock News
CRL reports Q4 revenue of $1B amid biotech spending constraints. Plans $350M stock buyback for 2025 despite projecting 3.5-5.5% organic revenue decline.
Read more
2024-09-29 (marketbeat.com)
APG Asset Management N.V. Raises Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
APG Asset Management N.V. increased its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 11.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 61,017 shares of the medical research compa
Read more
2024-09-28 (defenseworld.net)
Xponance Inc. Sells 130 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)
Read Xponance Inc. Sells 130 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) at Defense World
Read more
2024-09-21 (etfdailynews.com)
MQS Management LLC Buys Shares of 1,561 Charles River Laboratories International, Inc. (NYSE:CRL)
Read MQS Management LLC Buys Shares of 1,561 Charles River Laboratories International, Inc. (NYSE:CRL) at ETF Daily News
Read more
2024-09-09 (defenseworld.net)
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Rhumbline Advisers
Read Charles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Rhumbline Advisers at Defense World
Read more
2024-08-07 (stocktitan.net)
Charles River Laboratories Announces Second-Quarter 2024 Results
Charles River Labs Q2 results: Revenue down 3.2%, EPS mixed. New $1B stock buyback approved. Challenges persist, forcing revised 2024 guidance. Dive into the financial details and market implications.
Read more
2024-02-01 (163.com)
U.S. stocks rebounded the next day after a sharp decline. NVIDIA returned to a new all-time high and its market capitalization surpassed Google. China Concept outperformed the market for the second time this week. Bitcoin rushed towards $52,000.
The U.S. CPI released on Tuesday unexpectedly showed signs of a pickup in inflation, dampening market expectations for interest rate cuts. The current market pricing fully reflects the extent of the Federal Reserve's interest rate cuts this year, which is consistent with the expected number of interest rate cuts announced by the Federal Reserve in December last year. Traders also expect about 70% to rise during the year
Read more
2023-12-10 (marketbeat.com)
Thrivent Financial for Lutherans Has $7.18 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
Thrivent Financial for Lutherans lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1,464.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,164 sha
Read more
(investing.com)
Charles River Laboratories Share Price Today | NYSE CRL Stock - Investing.com India
View the real-time Charles River Laboratories (NYSE CRL) share price and assess historical data, charts, technical analysis and the share chat forum.
Read more